benicar hct shortage


First approved by the U.S. Food and Drug Administration (FDA) in 1995, studies have shown a link between Benicar's active ingredient, olmesartan, and certain severe side effects. The content on this page is provided for informational purposes only.

Sprue-like enteropathy can lead to significant weight loss and, Patients or their surviving family members have filed lawsuits against Daichii Sankyo and Forest Laboratories for failing to warn them about dangerous Benicar side effects.

At ConsumerSafety.org, Curtis managed the day-to-day publication of all content from 2016-2019.Medications That Cause Depression Could Be a Bigger Problem Than First Thought© 2020 CSO Technology Partners, LLC. Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Benicar HCT. Other similar drugs, known as sartans, have recently been the subject of numerous recalls due to carcinogenic contaminants found in test lots. *See below for Eligibility Criteria and Terms & Conditions. is longer reviewing new cases. U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 1-888-INFO-FDA (1-888-463-6332) Contact FDA This website does not provide medical advice, probable diagnosis, or recommended treatments.Curtis Weyant has more than 20 years as a writer, editor, and communicator, publishing on a wide variety of topics, especially in the financial, legal, and medical fields. Tell your doctor if you are experiencing these symptoms.Serious side effects may also include severe, chronic diarrhea with considerable weight loss, which may develop months to years after starting BENICAR, BENICAR HCT, AZOR, or TRIBENZOR. was reached with the drug makers to resolve certain claims for injuries stemming from use of Benicar, Benicar HCT, Azor or Tribenzor prior to May 2015.

Medicines that lower blood pressure lower the chance of having a stroke or heart attack.Patients may require more than one type of blood pressure lowering medication.

ALL RIGHTS RESERVED. Take BENICAR, BENICAR HCT, AZOR, or TRIBENZOR as prescribed by your doctor. Tell your doctor if you have signs of a change in body salts and body fluids.

If you find any errors, please let us know using our Benicar lawsuits were filed as a result of drug-associated severe, life-threatening side effects like sprue-like enteropathy, colitis, and other gastrointestinal problems. Other less common side effects were blood pressure that is too low; blood pressure that becomes too low after standing up too quickly; rash; itching; pounding or racing heartbeat; more frequent urination; and excessive urination at night. These signs may also include confusion, seizures, muscle pains or cramps, muscle tiredness, dizziness or fainting, having little or no urine, fast heartbeat, and nausea and vomiting.The thiazide diuretic in TRIBENZOR can also cause eye problems which may lead to vision loss. The thiazide diuretic in BENICAR HCT can also cause eye problems, which may lead to vision loss.

Dizzy These medications may be counterfeit and potentially unsafe. Photos depict models, not actual patients or healthcare professionals. If you have kidney problems, you may need blood tests, and your doctor may need to lower your dose.

Symptoms can happen within hours to weeks of starting TRIBENZOR.

Injury reports and studies led the FDA to approve label changes for Benicar, Benicar HCT, Azor and Tribenzor in 2013. Daiichi Sankyo, Inc. is not responsible for, and disclaims any liability to, the content of any other pages or site or for any viruses or similar harmful programs that may be present on such pages or sites.

Along with lowering blood pressure, a complete treatment plan to lower the chance of a stroke or heart attack may include exercise, a diet low in sodium, stopping smoking, controlling cholesterol, treatment or prevention of blood clots, and controlling blood sugar.BENICAR, BENICAR HCT, AZOR, and TRIBENZOR may be used alone or with other medicines to treat high blood pressure.AZOR may be used as the first medicine to treat high blood pressure in people who are likely to need more than 1 blood pressure medicine to reach their blood pressure goals.AZOR is not for use as the first medicine to treat high blood pressure for people who are 75 years of age and older or have liver problems.BENICAR HCT and TRIBENZOR are not for use as the first medicine to treat high blood pressure.Do not take BENICAR, BENICAR HCT, AZOR, or TRIBENZOR if you:Children that are less than 1 year of age must not receive BENICAR for high blood pressure.
The U.S. Food and Drug Administration has not yet issued a recall for Benicar despite the fact that the drug has been linked to dangerous side-effects. While a handful of cases are still working their way through federal courts, we are no longer taking new Benicar cases.The Benicar settlement totals $358 million and covers more than 2,200 cases.
Saiontz & Kirk, P.A. DESCRIPTION. Daiichi Sankyo, Inc. has not reviewed the contents of all the pages and sites that may be linked to this site. The most notable is sprue-like enteropathy, a serious gastrointestinal condition sometimes mistaken for celiac disease. A handful of plaintiffs who rejected the settlement are still pursuing their cases in the District of New Jersey.No. Daiichi Sankyo is no longer participating in the RxDirect Program. BENICAR HCT (olmesartan medoxomil and hydrochlorothiazide) is a combination of an angiotensin II receptor antagonist (AT 1 subtype), olmesartan medoxomil, and a thiazide diuretic, hydrochlorothiazide (HCTZ).. Olmesartan medoxomil is 2,3-dihydroxy-2-butenyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[p-(o-1Htetrazol- 5-ylphenyl)benzyl]imidazole-5-carboxylate, cyclic … Get medical help right away if you have chest pain that gets worse or does not go away. Call your doctor for medical advice about side effects.To contact us with questions or concerns about a Daiichi Sankyo product, please call us:All FDA-approved drugs have product information, a document that contains information healthcare providers need to know when prescribing FDA-approved drugs.Please Note: You are now leaving a Daiichi Sankyo, Inc. site.